ロード中...
Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma
Medulloblastoma (MB) is the most common malignant primary pediatric brain cancer. Among the most aggressive subtypes, Group 3 and Group 4 originate from stem/progenitor cells, frequently metastasize, and often display the worst prognosis, yet we know the least about the molecular mechanisms driving...
保存先:
| 出版年: | Mol Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5891039/ https://ncbi.nlm.nih.gov/pubmed/29377567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12177 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|